首页> 外文期刊>Respiratory medicine >Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HRrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
【24h】

Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HRrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?

机译:评估慢性阻塞性肺疾病(COPD)和射血分数降低的心力衰竭(HRrEF)出院药物是否开处方:药物治疗是否符合国家准则,可减少30天再入院?

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Approximately 1 in 5 hospitalized COPD patients are readmitted within 30 days of discharge. CHF coexists in more than 20% of patients with COPD, and is associated with early readmission for COPD. Reducing 30-day hospital readmissions for COPD is of intense current interest.
机译:简介:出院后30天内,约有五分之一的住院COPD患者重新入院。 CHF并存于20%以上的COPD患者中,并且与COPD的早期再入院有关。减少COPD的30天住院治疗是当前引起人们强烈关注的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号